Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
North America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The North America next-generation antibody market is expected to reach US$ 5,428.80 million by 2028 from US$ 2,457.09 million in 2021. It is estimated to grow at a CAGR of ... Read More
-
Middle East and Africa Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... & antibody-like proteins, and Biosimilar antibody products) The Middle East and Africa (MEA) next-generation antibody market is expected to reach US$ 450.75 million by 2028 from US$ 222.59 million in 2021. It is estimated to ... Read More
-
Asia Pacific Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The Asia Pacific (APAC) next-generation antibody market is expected to reach US$ 2,312.68 million by 2028 from US$ 999.49 million in 2021. It is estimated to grow at a CAGR ... Read More
-
Europe Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... and Biosimilar antibody products) The Europe next-generation antibody market is expected to reach US$ 3,162.30 million by 2028 from US$ 1,455.32 million in 2021. It is estimated to grow at a CAGR of 11.7% from ... Read More
-
South and Central America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... & antibody-like proteins, and Biosimilar antibody products) The South and Central America (SCAM) next-generation antibody market are expected to reach US$ 695.60 million by 2028 from US$ 333.92 million in 2021. It is estimated to ... Read More
-
Pharmaceuticals Market Covering Pharmaceutical Drugs; Biologics; Global Summary 2021: Covid 19 Impact and Recovery
... global pharmaceuticals market is expected to grow from $1228.4 billion in 2020 to $1700.95 billion in 2025 at a CAGR of 6.72%. Pharmaceuticals Market Covering Pharmaceutical Drugs; Biologics; Global Summary 2021: Covid 19 Impact and ... Read More
-
Biologics Market Covering Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines; Global Summary 2021: Covid 19 Impact and Recovery
... of 8.65%. The global biologics market is expected to grow from $253.4 billion in 2020 to $420.57 billion in 2025 at a CAGR of 10.66%. Biologics Market Covering Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines; Global ... Read More
-
Biologics Contract Development and Manufacturing Organization (CDMO) - Global Market Outlook (2021 - 2028)
... and is expected to reach $25.75 billion by 2028 growing at a CAGR of 12.9% during the forecast period. Biologics contract development and manufacturing organizations offer complete services from cell line development to long term ... Read More
-
Cell Culture Media Market by Type(Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application(Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User(Pharma, Biotech) - Global Forecast to 2026
... Global Forecast to 2026 The global cell culture media market is projected to USD USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0 % between 2021 and 2026.The ... Read More
-
Global Vaccine Packaging Market Size study, by Packaging Type (Vaccine Cool Bags, Vials and Ampoules, Corrugated Boxes, Others) by Packaging Level (Primary, Secondary, Tertiary) by End User (Biopharmaceutical Companies, Hospitals, Medical Laboratories, Others)) and Regional Forecasts 2022-2028
... Forecasts 2022-2028Global Vaccine Packaging Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Vaccine packaging ... Read More
-
Single-use Bioprocessing Market By Product (Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Filter Cartridges, Media Bags And Containers, Mixing Systems, Tubing Assemblies, Sampling Systems, Others), By Application (Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, Others), By Method (Filtration, Storage, Cell Culture, Mixing, Purification), By End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, Contract Research Organization & Manufacturers): Global Opportunity Analysis and Industry Forecast, 2020-2030
... Patient Specific Cell Therapies, Others), By Method (Filtration, Storage, Cell Culture, Mixing, Purification), By End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, Contract Research Organization & Manufacturers): Global Opportunity Analysis and Industry ... Read More
-
In Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Organization Size (Large Organizations, Small and Medium Organizations); Offering (Products, Platform, Services); Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, Others); Clinical Indication (Cardiovascular Disease, Neurodegenerative Disease, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, Others); End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, Others), and Geography
... Platform, Services); Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, Others); Clinical Indication (Cardiovascular Disease, Neurodegenerative Disease, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, ... Read More
-
Clinical Trial Management Market by Type (Enterprise-Based and Site-Based), Delivery Mode (Web-Based, On-Premise, and Cloud-Based), Component (Software and Services), and End User (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, and Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2021––2030
... and Industry Forecast, 2021––2030 The global clinical trial management market was valued at $969.4 million in 2020, and is estimated to reach $ 2,810.5 million by 2030, growing at a CAGR of 11.2% from 2021 ... Read More
-
Cell Culture Market by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) - Global Forecast to 2026
... is projected to USD 41.3 billion by 2026 from USD 22.8 billion in 2021, at a CAGR of 12.6 % between 2021 and 2026. The growth of this market is majorly driven by the growing ... Read More
-
Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Category (Biologics, Medical Devices), By Company Size (Medium, Large), By Indication, By Stage, By Services, By End Use, And Segment Forecasts, 2022 - 2030
... new report by Grand View Research, Inc. Significant increase in the fixed costs of in-house resources for regulatory affairs & operation activities like training, technology, specialized knowledge, and facilities are driving outsourcing of regulatory affair ... Read More
-
Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Biologics and Biosimilar); Service (Process Development, Fill and Finish Operations, Analytical and Quality Control Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian), and Geography
... and Microbial-Based Biologics/Non-Mammalian), and Geography The biopharmaceutical contract manufacturing market is projected to reach US$ 27,868.50 million by 2028 from US$ 15,735.04 million in 2021; it is expected to grow at a CAGR of 8.5% ... Read More
-
Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities
... of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence of small and midsize biotechnology companies drive bio-CDMOs toward becoming end-to-end integrated service providers for better ... Read More
-
Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical {Single Use Technology, and Others, Medical Devices, Research and Development, and Others)
... tubing market is expected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The factors increasing elderly ... Read More
-
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Generic Drugs Market ... Read More
-
India Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 India Generic Drugs Market to Grow at 11% during 2022 – 2028 India generic drugs ... Read More
-
Healthcare Cold Chain Monitoring Market: Information by Component (Hardware (Sensors, Data Loggers, Real-Time Monitoring Devices, RFID Devices, Resistance Temperature Detectors, and Others), Software (Cloud Based and On-Premises),Temperature Type (Frozen and Chilled), Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others),End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027
... Trial Materials, and Others),End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027 Healthcare Cold Chain Monitoring Market—Forecast till 2027 Market Overview ... Read More
-
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 Including: 1) By Technology: Deep Learning; Machine Learning 2) By Drug Type: Small Molecule; Large Molecules 3) By Therapeutic Type: Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Others 4) By End-Users: Pharmaceutical Companies; Biopharmaceutical Companies; Academic And Research Institutes; Others Covering: IBM Corporation; Microsoft; Atomwise Inc.; Deep Genomics; Cloud Pharmaceuticals; Insilico Medicine
... in drug discovery market. This report focuses on artificial intelligence (ai) in drug discovery market which is experiencing strong growth. The report gives a guide to the artificial intelligence (ai) in drug discovery market which ... Read More
-
Genomics Global Market Report 2022 Including: 1) By Product Type: Instrument (Including Systems, Service Contract And Software); Reagents (Including Reagents And Consumables) 2) By Process: Cell Isolation; Sample Preparation; Genomic Analysis 3) By End User: Academic Institutes; Biopharmaceutical Companies; Clinical Research Institutes Covering: 10X Genomics; Qiagen NV; Fluidigm Corporation; Johnson & Johnson Private Limited; Zephyrus Biosciences Inc.; Illumina Inc.
... which is experiencing strong growth. The report gives a guide to the genomics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the ... Read More
-
Global Non-oncology Biopharmaceuticals Market - 2021-2028
... of XX % during the forecast period (2021-2028). Biopharmaceuticals are part of the wider category of therapeutic agents called biologics. Biopharmaceuticals are substances developed in living systems with the help of biotechnology and are used ... Read More
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
... Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route ... Read More
Research Assistance
